Results of delayed triage by HPV testing and cytology in the Norwegian Cervical Cancer Screening Programme

References

• Council of the European Union. Council recommendation of 2 December 2003 on cancer screening (2003/878/EC). Off J Eur Union 2003;L327:34–8.
   Google Scholar
• IARC Handbooks of Cancer Prevention Volume 10. Cervix cancer screening. Lyon, France: IARC Press; 2005.
   Google Scholar
• European Commision. European Guidelines for Quality Assurance in Cervical Cancer Screening, 2nd edition. Luxembourg: Office for Official Publications of the European Communities; 2008.
   Google Scholar
• Jordan J, Arbyn M, Martin-Hirsch P, Schenck U, Baldauf JJ, Da SD, et al. European guidelines for quality assurance in cervical cancer screening: Recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology 2008;19:342–54.
   PubMed Web of Science ®Google Scholar
• Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012;62:147–72.
   PubMed Web of Science ®Google Scholar
• Ronco G, van Ballegooijen M, Becker N, Chil A, Fender M, Giubilato P, et al. Process performance of cervical screening programmes in Europe. Eur J Cancer 2009;45:2659–70.
   PubMed Web of Science ®Google Scholar
• Anttila A, von Karsa L, Aasmaa A, Fender M, Patnick J, Rebolj M, et al. Cervical cancer screening policies and coverage in Europe. Eur J Cancer 2009;45:2649–58.
   PubMed Web of Science ®Google Scholar
• Coleman D, Day N, Douglas G, Farmery E, Lynge E, Philip J, et al. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme. Eur J Cancer 1993;29A(Suppl 4):S1–38.
   Google Scholar
• ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188:1393–400.
   PubMed Web of Science ®Google Scholar
• ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383–92.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J. Virologic versus cytologic triage of women with equivocal Pap smears: A meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004;96:280–93.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 2012;30(Suppl 5):F88–99.
   Google Scholar
• Moss S, Gray A, Legood R, Vessey M, Patnick J, Kitchener H. Effect of testing for human papillomavirus as a triage during screening for cervical cancer: Observational before and after study. Br Med J 2006;332:83–5.
   PubMedGoogle Scholar
• Kelly RS, Patnick J, Kitchener HC, Moss SM. HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: Results from the Sentinel Sites study. Br J Cancer 2011;105:983–8.
   PubMed Web of Science ®Google Scholar
• Faglig rådgivningsgruppe for Masseundersøkelsen mot livmorhalskreft. Kvalitetsmanual. Masseundersøkelsen mot livmorhalskreft. Oslo: Kreftregisteret; 2005.
   Google Scholar
• Nygard JF, Skare GB, Thoresen SO. The cervical cancer screening programme in Norway, 1992–2000: Changes in Pap smear coverage and incidence of cervical cancer. J Med Screen 2002;9:86–91.
   PubMed Web of Science ®Google Scholar
• Johansen BK, Bjørge T. Cervical cancer screening in Norway. In: Haldorsen T, editor. Cancer in Norway 2009. Special issue: Cancer screening in Norway. Oslo: Cancer Registry of Norway; 2011. p. 118–29.
   Google Scholar
• Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M, et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002;287: 2114–9.
   PubMed Web of Science ®Google Scholar
• Nygård M, Røysland K, Cambell S, Dillner J. Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme. Br Med J Open 2013;4:e003460. doi:10.1136/bmjopen-2013-003460.
   Google Scholar
• Cleves MA, Gould WW, Gutierrez RG. An introduction to survival analysis using stata. Revised edition. College Station, Texas: Stata Press; 2004.
   Google Scholar
• Stata: Release 11. Statistical Software. [computer program]. College Station, Texas: StataCorp LP; 2009.
   Google Scholar
• Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M. Risk assessment to guide the prevention of cervical cancer. J Low Genit Tract Dis 2008;12:1–7.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Roelens J, Martin-Hirsch P, Leeson S, Wentzensen N. Use of HC2 to triage women with borderline and mild dyskaryosis in the UK. Br J Cancer 2011;105:877–80.
   PubMed Web of Science ®Google Scholar
• Cuzick J, Thomas CJ, Zhang G, Einstein MH, Stoler M, Trupin S, et al. Human papillomavirus testing for triage of women with low-grade squamous intraepithelial lesions. Int J Cancer 2013;132:959–66.
   PubMed Web of Science ®Google Scholar
• Nygard JF, Sauer T, Nygard M, Skare GB, Thoresen SO. CIN 2/3 and cervical cancer in an organised screening programme after an unsatisfactory or a normal Pap smear: A seven-year prospective study of the Norwegian population-based screening programme. J Med Screen 2004;11:70–6.
   PubMed Web of Science ®Google Scholar